Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform

Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform

Abstract Background The analysis of the main features of randomized controlled trials (RCTs) on ANCA-associated vasculitis (AAV) can inform future study design. Methods We searched within the International Clinical Trials Registry Platform all registered RCTs on AAV from October 2008 to December 201...

Full description

Bibliographic Details
Main Authors:	Michele Iudici, Xavier Puéchal, Alejandro Brigante, Ignacio Atal, Cem Gabay
Format:	Article
Language:	English
Published:	BMC 2020-05-01
Series:	Orphanet Journal of Rare Diseases
Subjects:	ANCA-vasculitis Randomized controlled trial Epidemiology
Online Access:	http://link.springer.com/article/10.1186/s13023-020-01408-6

Similar Items

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
by: Rui Wu, et al.
Published: (2021-03-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
by: Precil Diego Miranda de Menezes Neves, et al.
Published: (2021-08-01)

The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
by: José Agapito Fonseca, et al.
Published: (2021-05-01)

The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
by: José Agapito Fonseca, et al.
Published: (2021-05-01)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
by: Gwen E. Thompson, et al.
Published: (2020-09-01)

Propylthiouracil-induced ANCA-negative cutaneous small vessel vasculitis
by: Aliaksandr Trusau, et al.
Published: (2018-01-01)

A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
by: Marenao Tanaka, et al.
Published: (2017-11-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

ANCA-associated vasculitis in childhood: recent advances
by: Marta Calatroni, et al.
Published: (2017-05-01)

The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China
by: Jiannan Li, et al.
Published: (2018-10-01)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
by: Marinchev Liubomir, et al.
Published: (2013-10-01)

Nasal microbiome research in ANCA-associated vasculitis: Strengths, limitations, and future directions
by: Andreas Kronbichler, et al.
Published: (2021-01-01)

Reporte de un caso: Vasculitis asociada a ANCA P en el adulto mayor
by: Osvaldo Cardozo
Published: (2020-05-01)

Persistent hematuria in patients with antineutrophil cytoplasmic antibody-associated vasculitis during clinical remission: chronic glomerular lesion or low-grade active renal vasculitis?
by: Li Lv, et al.
Published: (2017-12-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
by: Yusuke Miyazaki, et al.
Published: (2020-06-01)

Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-03-01)

Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies
by: Magdalena Mosakowska, et al.
Published: (2021-08-01)

ANCA-Associated Vasculitis Clinical Presentation and Clinical Predictors of Relapse in Saudi Arabia
by: Alahmari H, et al.
Published: (2021-07-01)

ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
by: Valentine Gillion, et al.
Published: (2017-03-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

Benzylthiouracil-induced ANCA-associated Vasculitis: A Case Report and Literature Review
by: Fatima Bensiradj, et al.
Published: (2019-12-01)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
by: Sayo Takeda, et al.
Published: (2019-06-01)

ANCA-ASSOCIATED VASCULITIS: HETEROGENEITY OF CLINICAL MANIFESTATIONS, PROGNOSIS, CURRENT OPPORTUNITIES OF PHARMACOTHERAPY
by: O.B. Yaremenko, et al.
Published: (2017-11-01)

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
by: Stefanie Eindhoven, et al.
Published: (2017-12-01)

Fatal pulmonary complication during induction therapy in a patient with ANCA-associated vasculitis
by: Brigita Jonaitytė, et al.
Published: (2016-07-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
by: Dimitrios Chanouzas, et al.
Published: (2019-02-01)

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
by: N M Bulanov, et al.
Published: (2018-06-01)

Clinical value of determining the markers of vascular wall damage in patients with ANCA-associated vasculitis and polyarteritis nodosa
by: L. B. Petelytska, et al.
Published: (2020-02-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
by: Daisuke Tsukui, et al.
Published: (2021-01-01)

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis
by: Janina Müller-Deile, et al.
Published: (2021-06-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
by: Désirée Tampe, et al.
Published: (2021-09-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

ST Elevation Myocardial Infarction as Presenting Feature of C-ANCA Vasculitis: A Case of a Diagnostic Dilemma
by: Abdulrahman S Museedi, et al.
Published: (2020-05-01)